BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15679136)

  • 1. Malignant hyperthermia with excellent response to small dose of dantrolene.
    Chang KY; Ting CK; Chan KH; Tsai SK
    Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey for prevention and treatment of malignant hyperthermia in Taiwan.
    Yip WH; Mingi CL; Ooi SJ; Chen SC; Chiang YY
    Acta Anaesthesiol Taiwan; 2004 Sep; 42(3):147-51. PubMed ID: 15551892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dantrolene sodium in the treatment of malignant hyperthermia. A case report.
    Harrison GG
    S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dantrolene in human malignant hyperthermia.
    Kolb ME; Horne ML; Martz R
    Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dantrolene for malignant hyperthermia during anesthesia.
    Med Lett Drugs Ther; 1980 Jul; 22(15):61-2. PubMed ID: 7393124
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
    Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
    Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia during a laparoscopic operation.
    Watari A; Kobori H; Yamamoto T
    J Minim Invasive Gynecol; 2011; 18(6):809-11. PubMed ID: 22024269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
    Blank JW; Boggs SD
    J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halothane induced porcine malignant hyperthermia reversed by dantrolene.
    Alitalo I; Schulman A
    Nord Vet Med; 1983; 35(5-6):239-42. PubMed ID: 6889129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
    Brandom BW; Larach MG; Chen MS; Young MC
    Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly delayed postoperative malignant hyperthermia.
    Souliere CR; Weintraub SJ; Kirchner JC
    Arch Otolaryngol Head Neck Surg; 1986 May; 112(5):564-6. PubMed ID: 3954899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant hyperthermia: clinical course and metabolic changes in two patients.
    Rutberg H; HÃ¥kanson E
    Acta Anaesthesiol Scand; 1986 Apr; 30(3):211-4. PubMed ID: 3739577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.
    Larach MG; Gronert GA; Allen GC; Brandom BW; Lehman EB
    Anesth Analg; 2010 Feb; 110(2):498-507. PubMed ID: 20081135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hyperthermia testing in probands without adverse anesthetic reaction.
    Timmins MA; Rosenberg H; Larach MG; Sterling C; Kraeva N; Riazi S
    Anesthesiology; 2015 Sep; 123(3):548-56. PubMed ID: 26068069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
    Flewellen EH; Nelson TE
    Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New findings and experiences in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-onset malignant hyperthermia in the postanesthetic care unit: a case report.
    Min JY; Hong SH; Kim SJ; Chung MY
    J Int Med Res; 2021 Sep; 49(9):3000605211044201. PubMed ID: 34586942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.